DE202007015417U1 - Preparation for the control of herpes labialis, herpes vaginalis, psoriasis, pain of 1st and 2nd degree burns, infected areas of the skin and atopic dermatitis - Google Patents

Preparation for the control of herpes labialis, herpes vaginalis, psoriasis, pain of 1st and 2nd degree burns, infected areas of the skin and atopic dermatitis Download PDF

Info

Publication number
DE202007015417U1
DE202007015417U1 DE202007015417U DE202007015417U DE202007015417U1 DE 202007015417 U1 DE202007015417 U1 DE 202007015417U1 DE 202007015417 U DE202007015417 U DE 202007015417U DE 202007015417 U DE202007015417 U DE 202007015417U DE 202007015417 U1 DE202007015417 U1 DE 202007015417U1
Authority
DE
Germany
Prior art keywords
herpes
preparation
psoriasis
pain
atopic dermatitis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE202007015417U
Other languages
German (de)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ALEXA EDMOND
Alexa Mihai Dipl-Chem Dr
Original Assignee
ALEXA EDMOND
Alexa Mihai Dipl-Chem Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ALEXA EDMOND, Alexa Mihai Dipl-Chem Dr filed Critical ALEXA EDMOND
Priority to DE202007015417U priority Critical patent/DE202007015417U1/en
Publication of DE202007015417U1 publication Critical patent/DE202007015417U1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/886Aloeaceae (Aloe family), e.g. aloe vera
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/12Ketones
    • A61K31/122Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/70Polygonaceae (Buckwheat family), e.g. spineflower or dock
    • A61K36/708Rheum (rhubarb)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/72Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Präparat zur Bekämpfung von Herpes labiales, Herpes vaginales, Psoriasis, Schmerzen durch Verbrennungen 1.ten und 2.ten Grades, Neurodermitis und infizierte Hautpartien ohne klare Ätiologie, gekennzeichnet durch ein Gehalt an mindestens 95% Antrachinonen aus Aloe, Frangula, Chrysophanol oder Rheum besteht.Preparation for fight from herpes labiales, vaginal herpes, psoriasis, pain from burns 1st and 2nd degree, atopic dermatitis and infected skin without a clear etiology, characterized by a content of at least 95% anthraquinones Aloe, Frangula, Chrysophanol or Rheum.

Description

Die Erfindung betrifft ein Präparat zur Bekämpfung von Herpes labiales, Herpes vaginales, Psoriasis, Schmerzen durch Verbrennungen 1.ten und 2.ten Grades, Neurodermitis und infizierte Hautpartien ohne klare Ätiologie.The The invention relates to a preparation for fighting from herpes labiales, vaginal herpes, psoriasis, pain through 1st and 2nd degree burns, atopic dermatitis and infected Skin without clear etiology.

Der Erfindung liegt die Aufgabe zugrunde ein Präparat zu schaffen, welches darauf zielt Herpes labiales, Herpes vaginales, Psoriasis, Schmerzen durch Verbrennungen 1.ten und 2.ten Grades, Neurodermitis und infizierte Hautpartien ohne klare Ätiologie zu bekämpfen beziehungsweise zu lindern.The invention has for its object to provide a preparation which aims herpes labial, herpes vaginal, to combat pain caused by burns first and second th th degree, atopic dermatitis and infected skin areas with no clear etiology or alleviate psoriasis.

Zur Lösung dieser Aufgabe durch die Erfindung sind die kennzeichnenden Merkmale des Anspruchs 1 vorgesehen. Auf der Basis des Wirkstoffes, welcher mindestens zu 95% Antrachinonen aus Aloe, Frangula, Chrysophanol oder Rheum besteht, der als Aloe-Emodin berechnet wird, wird erreicht, dass die z.B. schmerzhaften Erscheinungen bei Herpes und Verbrennungen sofort gelindert werden, sowie den Juckreiz bei Psoriasis und Neurodermitis zu eliminieren.to solution This object by the invention are the characterizing features of claim 1 provided. On the basis of the active substance, which at least 95% of anthraquinones from aloe, frangula, chrysophanol or Rheum, which is calculated as aloe-emodin, is achieved that the e.g. painful manifestations of herpes and burns be relieved immediately, as well as the itching in psoriasis and atopic dermatitis to eliminate.

Weitere Einzelheiten der Erfindung ergeben sich aus den mm folgenden Beschreibungen:Further Details of the invention will become apparent from the following descriptions:

Beispiel 1:Example 1:

1 g Antrakinonderivate oder Aloe-Emodine oder Frangula-Emodine oder Chrysophanol oder Rhein wird in einer 10 ml Mischung aus Polyglycol und Methanol gelöst, und weiter mit 10 ml Dimetylpolysiloxan vermischt.1 g Antrakinonderivate or Aloe-Emodine or Frangula-Emodine or Chrysophanol or Rhine is dissolved in a 10 ml mixture of polyglycol and Dissolved methanol, and further mixed with 10 ml Dimetylpolysiloxan.

Die rot-orange farbige Lösung kann direkt auf die Herpes-, Psoriasis- und Neurodermitisherden sowie auf verbrannten Hautpartien aufgetragen werden.The red-orange colored solution Can directly on the herpes, psoriasis and eczema herds as well be applied to burned areas of the skin.

Beispiel 2:Example 2:

1 g Antrakinonderivate oder Aloe-Emodine oder Frangula-Emodine oder Chrysophanol oder Rhein wird in einer 10 ml Mischung aus Polyglycol und Methanol gelöst, und weiter mit 10 ml Teebaumöl vermischt.1 g Antrakinonderivate or Aloe-Emodine or Frangula-Emodine or Chrysophanol or Rhine is dissolved in a 10 ml mixture of polyglycol and Dissolved methanol, and further mixed with 10 ml of tea tree oil.

Die rot-orange farbige Lösung kann direkt auf die Herpes-, Psoriasis- und Neurodermitisherden sowie auf verbrannten Hautpartien aufgetragen werden.The red-orange colored solution Can directly on the herpes, psoriasis and eczema herds as well be applied to burned areas of the skin.

Beispiel 3:Example 3:

Die in Beispiel 1 und 2 gewonnene Flüssigkeit kann zu einer Creme verarbeitet werden indem z.B. 5–10 g Lamette N in ca. 80 mi Wasser bei ca. 70°C gelöst wird und durch konstantes rühren und hinzufügen der rot-orangenen Flüssigkeit eine gelbliche Creme entsteht. Diese kann direkt auf die Hautpartien aufgetragen werden.The in Example 1 and 2 recovered liquid can be made into a cream by e.g. 5-10 g of lamella N in about 80 mi of water at about 70 ° C solved will and by constant stirring and add the red-orange liquid a yellowish cream is created. This can be directly on the skin be applied.

Claims (5)

Präparat zur Bekämpfung von Herpes labiales, Herpes vaginales, Psoriasis, Schmerzen durch Verbrennungen 1.ten und 2.ten Grades, Neurodermitis und infizierte Hautpartien ohne klare Ätiologie, gekennzeichnet durch ein Gehalt an mindestens 95% Antrachinonen aus Aloe, Frangula, Chrysophanol oder Rheum besteht.preparation for fighting from herpes labiales, vaginal herpes, psoriasis, pain through 1st and 2nd degree burns, atopic dermatitis and infected Skin without clear etiology, characterized by a content of at least 95% anthraquinones Aloe, Frangula, Chrysophanol or Rheum. Präparat, gekennzeichnet wie unter 1.), das in flüssiger Form auch Teebaumöl oder andere Öle oder andere Lösungsmittel enthält.Preparation, characterized as in 1.), which in liquid form also tea tree oil or other oils or other solvent contains. Präparat, gekennzeichnet wie unter 1), das in flüssiger Form auch Dimetylpolysiloxan und/oder Polyethylenglycole enthält.Preparation, characterized as in 1), which in liquid form and Dimetylpolysiloxan and / or polyethylene glycols. Präparat, gekennzeichnet wie unter 1.), das als Creme verarbeitet werden kann.Preparation, characterized as under 1.), which can be processed as a cream. Präparat, gekennzeichnet wie unter 1.), das als Creme oder Flüssigkeit keine Konservierungsstoffe enthält.Preparation, characterized as in 1.), as a cream or liquid contains no preservatives.
DE202007015417U 2007-11-07 2007-11-07 Preparation for the control of herpes labialis, herpes vaginalis, psoriasis, pain of 1st and 2nd degree burns, infected areas of the skin and atopic dermatitis Expired - Lifetime DE202007015417U1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DE202007015417U DE202007015417U1 (en) 2007-11-07 2007-11-07 Preparation for the control of herpes labialis, herpes vaginalis, psoriasis, pain of 1st and 2nd degree burns, infected areas of the skin and atopic dermatitis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE202007015417U DE202007015417U1 (en) 2007-11-07 2007-11-07 Preparation for the control of herpes labialis, herpes vaginalis, psoriasis, pain of 1st and 2nd degree burns, infected areas of the skin and atopic dermatitis

Publications (1)

Publication Number Publication Date
DE202007015417U1 true DE202007015417U1 (en) 2008-02-21

Family

ID=39105712

Family Applications (1)

Application Number Title Priority Date Filing Date
DE202007015417U Expired - Lifetime DE202007015417U1 (en) 2007-11-07 2007-11-07 Preparation for the control of herpes labialis, herpes vaginalis, psoriasis, pain of 1st and 2nd degree burns, infected areas of the skin and atopic dermatitis

Country Status (1)

Country Link
DE (1) DE202007015417U1 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009133430A1 (en) * 2008-04-30 2009-11-05 Wockhardt Research Centre Topical compositions of rhein or diacerein
CN103908529A (en) * 2014-04-04 2014-07-09 青岛市城阳区人民医院 Traditional Chinese medicine ointment for treating roseola infantum
CN103919867A (en) * 2014-04-04 2014-07-16 青岛市城阳区人民医院 Traditional Chinese medicine ointment for treating roseola infantum
CN105106477A (en) * 2015-09-29 2015-12-02 成都倍加特生物科技有限公司 Decoction for treating generalized neurodermatitis and preparation method thereof

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009133430A1 (en) * 2008-04-30 2009-11-05 Wockhardt Research Centre Topical compositions of rhein or diacerein
CN103908529A (en) * 2014-04-04 2014-07-09 青岛市城阳区人民医院 Traditional Chinese medicine ointment for treating roseola infantum
CN103919867A (en) * 2014-04-04 2014-07-16 青岛市城阳区人民医院 Traditional Chinese medicine ointment for treating roseola infantum
CN103919867B (en) * 2014-04-04 2016-03-09 青岛市城阳区人民医院 A kind of traditional Chinese herb medicine for the treatment of roseola infantum
CN105106477A (en) * 2015-09-29 2015-12-02 成都倍加特生物科技有限公司 Decoction for treating generalized neurodermatitis and preparation method thereof

Similar Documents

Publication Publication Date Title
DE202007015417U1 (en) Preparation for the control of herpes labialis, herpes vaginalis, psoriasis, pain of 1st and 2nd degree burns, infected areas of the skin and atopic dermatitis
Nowossadeck et al. Krankheitsspektrum und Sterblichkeit im Alter
EP0103783A3 (en) Dermatological preparation
Felix et al. Über tyrosinosis
DE19821971C2 (en) Medicines for the treatment of psoriasis or atopic dermatitis
Demircioglu Familienvorstellungen und private Zukunftsentwürfe von Schülerinnen und Schülern in Deutschland
Buchka Erziehungskunst als Praktische Pädagogik–einige Gedanken zu ihrer systematischen Erhellung–
Kaltenbrunner Clark, Roland: Religious Reform and Sectarianism in Interwar Romania. The Limits of Orthodoxy and Nation-Building
Mackert The influence of extracorporeal shock wave therapy on the metaphyseal fracture healing in an osteoporotic rat model
Moeschlin Elektrolcardiographische Myokardschäden bei der Febris undulans Bang
Keck Technik, Gelassenheit und πόλεμος: pages: 283-295
Ruland Reformoptionen–die keine sind
Scherl Increasing life expectancy–the big social issue of the 21st century?
Alter Über die Unsicherheit bei der Berechnung von Sonnenfinsternissen
Tellkampf Das Gedachte oder das Denken lernen?-Das Gedachte und das Denken lernen! Zur Orientierung an Phänomenen und Problemen im Philosophieunterricht
Schaub Grundlagen und Beispiel für die Ableitung der scheinbaren Bahn eines Doppelsternes aus den relativen rechtwinkligen Koordinaten
Oana Geochemische Untersuchungen der Vulkane in Japan. XVIII. Dichtemessungen des durch Kondensation von Fumarolendampf erhaltenen Wassers
DE202007015418U1 (en) Preparation based on marmot fat with various essential oils
Vajta et al. EINIGE PROBLEME DER UNTERSUCHUNG VON ABWÄSSERN DER ERDÖLVERARBEITENDEN INDUSTRIE, II
Klawitter Mensch und Tier-eine paradoxe Beziehung aus neuer Sicht
Roggenkamp Höheres Rentenalter–Rentenkürzung
von Petersdorff Postmoderne. Bezeichnung eines Transformationsprozesses innerhalb der ästhetischen Moderne
Bauer Mittelfristige Einkommenskonsequenzen der Agrarpreispolitik
DE202007013342U1 (en) Skin lotion of two components without preservatives
Scherf et al. Herz-und Kreislaufneurosen und neurozirkulatorische Asthenie

Legal Events

Date Code Title Description
R086 Non-binding declaration of licensing interest
R079 Amendment of ipc main class

Free format text: PREVIOUS MAIN CLASS: A61K0036700000

Ipc: A61K0036708000

R207 Utility model specification

Effective date: 20080327

R156 Lapse of ip right after 3 years

Effective date: 20110601

Effective date: 20110531